We have made significant strides with our pipeline and Klarity™ Platform, thanks to the work of our internal team of intrepid scientists and our enabling and drug discovery collaborations. We thrive on bringing together diverse perspectives from both inside and outside of our company.
As we continue to unlock the potential of innovative therapeutics for neurological and metabolic diseases, we are particularly interested in industry or academic collaborations that further enable the understanding of gut cell targets and intersecting chemical matter in the following key therapeutic areas:
Neurological
Disorders
Metabolism
Partner With Us
If you are interested in partnering with us, please email Robert Barretto, PhD, at
